Logo image of RDIB

READING INTERNATIONAL INC-B (RDIB) Stock Fundamental Analysis

NASDAQ:RDIB - Nasdaq - US7554082005 - Common Stock - Currency: USD

10.33  +0.73 (+7.6%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to RDIB. RDIB was compared to 72 industry peers in the Entertainment industry. Both the profitability and financial health of RDIB have multiple concerns. RDIB is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RDIB had negative earnings in the past year.
RDIB had a negative operating cash flow in the past year.
RDIB had negative earnings in 4 of the past 5 years.
RDIB had a negative operating cash flow in each of the past 5 years.
RDIB Yearly Net Income VS EBIT VS OCF VS FCFRDIB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

RDIB has a Return On Assets (-6.08%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -6.08%
ROE N/A
ROIC N/A
ROA(3y)-6.47%
ROA(5y)-4.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RDIB Yearly ROA, ROE, ROICRDIB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

Looking at the Gross Margin, with a value of 10.43%, RDIB is doing worse than 81.94% of the companies in the same industry.
RDIB's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for RDIB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y33.38%
GM growth 5Y-12.85%
RDIB Yearly Profit, Operating, Gross MarginsRDIB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

More info and screens

0

2. Health

2.1 Basic Checks

RDIB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RDIB has more shares outstanding
The number of shares outstanding for RDIB has been increased compared to 5 years ago.
RDIB has a worse debt/assets ratio than last year.
RDIB Yearly Shares OutstandingRDIB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
RDIB Yearly Total Debt VS Total AssetsRDIB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -0.02, we must say that RDIB is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of RDIB (-0.02) is worse than 65.28% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.02
ROIC/WACCN/A
WACC12.01%
RDIB Yearly LT Debt VS Equity VS FCFRDIB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.23 indicates that RDIB may have some problems paying its short term obligations.
RDIB's Current ratio of 0.23 is on the low side compared to the rest of the industry. RDIB is outperformed by 90.28% of its industry peers.
A Quick Ratio of 0.22 indicates that RDIB may have some problems paying its short term obligations.
With a Quick ratio value of 0.22, RDIB is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.22
RDIB Yearly Current Assets VS Current LiabilitesRDIB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.20% over the past year.
Looking at the last year, RDIB shows a decrease in Revenue. The Revenue has decreased by -7.40% in the last year.
The Revenue has been decreasing by -5.33% on average over the past years.
EPS 1Y (TTM)18.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.41%
Revenue 1Y (TTM)-7.4%
Revenue growth 3Y14.81%
Revenue growth 5Y-5.33%
Sales Q2Q%-19.2%

3.2 Future

The Earnings Per Share is expected to grow by 27.65% on average over the next years. This is a very strong growth
Based on estimates for the next years, RDIB will show a quite strong growth in Revenue. The Revenue will grow by 9.94% on average per year.
EPS Next Y60.48%
EPS Next 2Y35.23%
EPS Next 3Y27.65%
EPS Next 5YN/A
Revenue Next Year9.3%
Revenue Next 2Y11.24%
Revenue Next 3Y9.94%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RDIB Yearly Revenue VS EstimatesRDIB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
RDIB Yearly EPS VS EstimatesRDIB Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RDIB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RDIB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RDIB Price Earnings VS Forward Price EarningsRDIB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

RDIB's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 248.21
RDIB Per share dataRDIB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

RDIB's earnings are expected to grow with 27.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.23%
EPS Next 3Y27.65%

More info and screens

0

5. Dividend

5.1 Amount

RDIB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

READING INTERNATIONAL INC-B

NASDAQ:RDIB (6/13/2025, 8:00:02 PM)

10.33

+0.73 (+7.6%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-12 2025-08-12/bmo
Inst Owners48.5%
Inst Owner Change4.04%
Ins Owners7.96%
Ins Owner Change0%
Market Cap232.22M
Analysts80
Price Target19.57 (89.45%)
Short Float %0.01%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.92%
Min EPS beat(2)37.06%
Max EPS beat(2)48.79%
EPS beat(4)2
Avg EPS beat(4)-39.32%
Min EPS beat(4)-128.48%
Max EPS beat(4)48.79%
EPS beat(8)2
Avg EPS beat(8)-412.07%
EPS beat(12)3
Avg EPS beat(12)-293.3%
EPS beat(16)4
Avg EPS beat(16)-231.87%
Revenue beat(2)1
Avg Revenue beat(2)0.97%
Min Revenue beat(2)-7.5%
Max Revenue beat(2)9.43%
Revenue beat(4)1
Avg Revenue beat(4)-6.33%
Min Revenue beat(4)-19.13%
Max Revenue beat(4)9.43%
Revenue beat(8)2
Avg Revenue beat(8)-5.59%
Revenue beat(12)3
Avg Revenue beat(12)-5.44%
Revenue beat(16)4
Avg Revenue beat(16)-5.25%
PT rev (1m)-6.05%
PT rev (3m)90.17%
EPS NQ rev (1m)-354.54%
EPS NQ rev (3m)-115.38%
EPS NY rev (1m)0%
EPS NY rev (3m)15.92%
Revenue NQ rev (1m)-10.53%
Revenue NQ rev (3m)-10.63%
Revenue NY rev (1m)-2.07%
Revenue NY rev (3m)-7.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.13
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 248.21
EPS(TTM)-1.2
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS9.15
BVpS-0.36
TBVpS-1.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.08%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.43%
FCFM N/A
ROA(3y)-6.47%
ROA(5y)-4.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y33.38%
GM growth 5Y-12.85%
F-Score6
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 82.92
Cap/Depr 25.78%
Cap/Sales 1.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.22
Altman-Z -0.02
F-Score6
WACC12.01%
ROIC/WACCN/A
Cap/Depr(3y)34.68%
Cap/Depr(5y)51%
Cap/Sales(3y)3.09%
Cap/Sales(5y)8.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.41%
EPS Next Y60.48%
EPS Next 2Y35.23%
EPS Next 3Y27.65%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.4%
Revenue growth 3Y14.81%
Revenue growth 5Y-5.33%
Sales Q2Q%-19.2%
Revenue Next Year9.3%
Revenue Next 2Y11.24%
Revenue Next 3Y9.94%
Revenue Next 5YN/A
EBIT growth 1Y-14.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year205.06%
EBIT Next 3Y60.72%
EBIT Next 5YN/A
FCF growth 1Y61.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.33%
OCF growth 3YN/A
OCF growth 5YN/A